hyperinflammatory phase

[키워드] 25OHD 25OHD deficiency 25OHD level 25OHD levels acute respiratory distress acute respiratory distress syndrome addition Admission angiotensin antimicrobial peptides Antiviral Antiviral agents approved ARDS association autophagy bradykinin calcifediol calcitriol Characteristics chemokine cholecalciferol coagulability complications Course Coverage COVID-19 COVID-19 pandemic Critical death described develop dose doses drug early stage early stages Effect effector mechanisms Endocrine endocrine system ENhance epithelial Evidence functional High dose Host hyperinflammatory phase ICU ICU admission include increased coagulability indication Infection integrity intensive care intensive care unit intervention study mechanical ventilation modulating mortality rate neutrophil Patient patients with SARS-CoV-2 pharmacokinetic pilot study prohormone prothrombotic public health systems RAAS reactive reduce Renin repositioning respiratory distress Respiratory distress syndrome risk SARS-CoV-2 SARS-COV-2 infection serum severe COVID-19 significantly subsequent syndrome System the disease therapeutic options Treatment treatment of COVID-19 vaccination variant VDES viral evolution Vitamin Vitamin D vitamin D endocrine system vitamin D endocrine system.
[DOI] 10.3390/nu14132716 PMC 바로가기 [Article Type] Review